Canadian hearing technology company cancels notes, issues shares
This article was originally published in Clinica
Executive Summary
Canadian auditory applications technology developer Sonomax Hearing Healthcare has added Can$300,000 (US$248,000) to working capital following the issue of the second tranche of a loan. Each Can$1 of principal amount was accompanied by two share warrants, exercisable at Can$0.22 per share. The company has also issued 12 million common shares at a price of $0.30 per share to four note holders. The issue is in connection with the company's repurchase and cancellation of unsecured convertible notes. Its state-of-the-art hearing aids and digital wireless SonoPlatform is due to be launched "later on this year via a new paradigm of quality, affordability, and consumer access", says Sonomax.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.